Volitionrx Ltd financial data

Symbol
VNRX on NYSE
Industry
In Vitro & In Vivo Diagnostic Substances
Location
1489 West Warm Springs Road, Suite 110, Henderson, NV
State of incorporation
DE
Fiscal year end
December 31
Former names
STANDARD CAPITAL CORP (to 9/29/2011)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 31.5 % -70.8%
Debt-to-equity -170 % +89.3%
Return On Equity 124 % -91.8%
Return On Assets -200 % -28.2%
Operating Margin -2.19K % +52.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.5M shares +17.6%
Common Stock, Shares, Outstanding 96.1M shares +17.3%
Entity Public Float 45.5M USD -44.6%
Common Stock, Value, Issued 96.1K USD +17.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.23M USD +59.1%
Research and Development Expense 14.4M USD -26.3%
Selling and Marketing Expense 5.36M USD -21.6%
General and Administrative Expense 8.49M USD -18.1%
Operating Income (Loss) -27M USD +24.9%
Nonoperating Income (Expense) 51K USD -96.3%
Net Income (Loss) Attributable to Parent -27.3M USD +23.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.26M USD -84.3%
Accounts Receivable, after Allowance for Credit Loss, Current 111K USD -54.4%
Other Assets, Current 343K USD -4.72%
Assets, Current 4.06M USD -81.4%
Property, Plant and Equipment, Net 4.43M USD -19.8%
Operating Lease, Right-of-Use Asset 600K USD +9.16%
Intangible Assets, Net (Excluding Goodwill) 215K USD +137%
Assets 9.4M USD -66.4%
Accounts Payable, Current 2.77M USD -13.9%
Accrued Liabilities, Current 3.48M USD -11.5%
Contract with Customer, Liability, Current 97.9K USD -22.7%
Liabilities, Current 7.79M USD -12.9%
Operating Lease, Liability, Noncurrent 411K USD +8.63%
Liabilities 35.5M USD -3.15%
Accumulated Other Comprehensive Income (Loss), Net of Tax 386K USD +58.1%
Retained Earnings (Accumulated Deficit) -230M USD -13.3%
Stockholders' Equity Attributable to Parent -24.9M USD -219%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -26.1M USD -200%
Liabilities and Equity 9.4M USD -66.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.34M USD +4.6%
Net Cash Provided by (Used in) Financing Activities -209K USD -103%
Net Cash Provided by (Used in) Investing Activities -78.8K USD +60.7%
Common Stock, Shares Authorized 175M shares 0%
Common Stock, Shares, Issued 96.1M shares +17.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.96M USD -946%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.26M USD -84.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 77.2K USD +50.5%
Depreciation 278K USD +10.6%
Payments to Acquire Property, Plant, and Equipment 28.8K USD -85.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -27.1M USD +24%
Property, Plant and Equipment, Gross 9.4M USD -3.18%
Operating Lease, Liability, Current 222K USD +11.3%
Additional Paid in Capital 204M USD +4.99%
Amortization of Intangible Assets 14.3K USD -32.3%
Share-based Payment Arrangement, Expense 335K USD -32.2%